Evidence map›Paper›PMID 38577429›Full record

ArticleRSC advances2024

Computational studies and synthesis of

Rizky Juwita Sugiharti, Rani Maharani, Fransiska Kurniawan, Rahmana Emran Kartasasmita, Daryono Hadi Tjahjono

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rizky Juwita SugihartiSchool of Pharmacy, Bandung Institute of Technology Bandung Indonesia daryonohadi@itb.ac.id.
Rani MaharaniDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran Jatinangor Indonesia r.maharani@unpad.ac.id.ORCID https://orcid.org/0000-0001-8156-9773
Fransiska KurniawanSchool of Pharmacy, Bandung Institute of Technology Bandung Indonesia daryonohadi@itb.ac.id.ORCID https://orcid.org/0000-0003-0885-1777
Rahmana Emran KartasasmitaSchool of Pharmacy, Bandung Institute of Technology Bandung Indonesia daryonohadi@itb.ac.id.
Daryono Hadi TjahjonoSchool of Pharmacy, Bandung Institute of Technology Bandung Indonesia daryonohadi@itb.ac.id.ORCID https://orcid.org/0000-0002-9675-0134
Bandung Institute of Technology · IDPadjadjaran University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiolabeled peptides belong to a highly specific group of radiotracers used in oncology, particularly for diagnostics and cancer therapy. With the notable advantages of high binding affinity and selectivity to cancer cells, they have proven to be very useful in nuclear medicine. As a result, efforts have been focused on discovering new peptide sequences for radiopeptide preparation. Nocardiotide A, a cyclic hexapeptide comprising the amino acids cyclo-Trp-Ile-Trp-Leu-Val-Ala (cWIWLVA) isolated from

Identifiers

PMID38577429
PMCPMC10993231
OpenAlexW4393938939

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.